Your session is about to expire
← Back to Search
Stem Cell Therapy
Human spinal cord stem cells. for Spinal Cord Injury (SCI Trial)
Phase 1
Waitlist Available
Led By Joseph Ciacci, MD
Research Sponsored by Neuralstem Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 60
Awards & highlights
SCI Trial Summary
This trial is testing a new treatment for spinal cord injury using stem cells.
Eligible Conditions
- Spinal Cord Injury
SCI Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 60
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 60
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adverse events and clinically significant laboratory abnormalities
Secondary outcome measures
Graft survival in the transplant site as determined by MRI (for Group A) and via autopsy, if one is completed.
Other outcome measures
EMG, SCIM, ISNC SCI, and Bowel and bladder follow-up
SCI Trial Design
1Treatment groups
Experimental Treatment
Group I: Surgical implantation of human spinal cord stem cellsExperimental Treatment1 Intervention
Surgical implantation of human spinal cord derived neural stem cells.
Find a Location
Who is running the clinical trial?
Neuralstem Inc.Lead Sponsor
6 Previous Clinical Trials
537 Total Patients Enrolled
Joseph Ciacci, MDPrincipal InvestigatorUCSD Medical Center, Division of Neurosurgery
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger